Current role
Alfonso Quintás-Cardama
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Foghorn Therapeutics Inc. (FHTX)
Proxy statement
Current
Company network
Recorded roles and earnings-call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Foghorn Therapeutics Inc. (FHTX) | Chief Medical Officer | $494,000 | $1,133,965 |
| 2024 | Foghorn Therapeutics Inc. (FHTX) | Chief Medical Officer | $471,000 | $769,489 |
| 2023 | Foghorn Therapeutics Inc. (FHTX) | Chief Medical Officer | $144,432 | $1,844,535 |
| 2022 | Foghorn Therapeutics Inc. (FHTX) | Chief Medical Officer | — | — |
Recent activity
No earnings-call appearances or filed executive changes recorded yet.